The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Neat-HER Virtual Registry: A novel registry following HER2+ ESBC patients receiving neratinib in the extended adjuvant setting.
 
Debu Tripathy
Consulting or Advisory Role - CellMax Life; Genomic Health; GlaxoSmithKline; Nektar; Novartis; Pfizer; Polyphor; Puma Biotechnology; Sellas Life Sciences
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Gregory A. Vidal
Consulting or Advisory Role - Lilly; Pfizer
Speakers' Bureau - AstraZeneca; Pfizer
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Lilly; Pfizer; Puma Biotechnology; Tesaro
 
Deepa Lalla
Employment - Puma Biotechnology
Consulting or Advisory Role - Aimmune; Genentech; Global Blood Therapeutics; Kite, a Gilead company
 
Richard Bryce
Employment - Puma Biotechnology
Leadership - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
Travel, Accommodations, Expenses - Puma Biotechnology
 
Gillian Hanson
Employment - PicnicHealth
Stock and Other Ownership Interests - PicnicHealth
Travel, Accommodations, Expenses - Roche
 
Melissa Brammer
Employment - Puma Biotechnology
 
Feng Xu
Employment - Puma Biotechnology
 
Hope S. Rugo
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech; Sanofi